Related Experiment Video

Updated: May 5, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

485

MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61

Jianhua Huang1, Kanda Gao, Jian Lin

  • 1Department of Orthopaedics, Affiliated People's First Hospital, Shanghai Jiaotong University, 200080, Shanghai, China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|December 10, 2013
PubMed

Insights

MicroRNA-100 (miR-100) is significantly decreased in osteosarcoma, acting as a tumor suppressor by inhibiting cell proliferation and targeting Cyr61. This finding offers potential diagnostic and therapeutic avenues for osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are crucial regulators of cellular processes.
  • Aberrant miRNA expression is linked to human cancer development.
  • Osteosarcoma (OS) is a primary bone cancer with limited treatment options.

Purpose of the Study:

  • To investigate the functional role of miR-100 in osteosarcoma.
  • To identify potential target genes of miR-100 in OS cells.
  • To explore miR-100 as a diagnostic and therapeutic target for osteosarcoma.

Main Methods:

  • Quantitative real-time PCR to assess miR-100 expression in OS tissues and cell lines.
  • Cell proliferation assays following miR-100 mimic or inhibitor transfection.
  • Western blot analysis to evaluate Cyr61 protein levels after miR-100 modulation.

Main Results:

  • miR-100 expression was significantly downregulated in osteosarcoma tissues compared to adjacent normal tissues.
  • Enforced miR-100 expression inhibited proliferation in Saos-2 and MG63 osteosarcoma cells.
  • Antisense miR-100 promoted cell proliferation.
  • miR-100 negatively regulated the expression of Cyr61, an extracellular matrix-associated growth factor.

Conclusions:

  • miR-100 functions as a tumor suppressor in osteosarcoma.
  • miR-100 inhibits osteosarcoma cell proliferation, partly through targeting Cyr61.
  • miR-100 represents a potential biomarker and therapeutic target for osteosarcoma.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

867

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

9.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K